Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Revenue | $7.97M | $8.40M | $10.1M |
| Revenue growth | — | 5.4% | 20.4% |
| Gross profit | $2.15M | $2.13M | $5.56M |
| Gross margin | 27.0% | 25.3% | 54.9% |
| Operating income | -$11.3M | -$14.9M | -$134M |
| Operating margin | -141.3% | -177.6% | -1323.6% |
| Net income | -$36.8M | $710K | -$138M |
| Net margin | -461.6% | 8.5% | -1360.9% |
| EPS (diluted) | -$96.45 | -$39.46 | -$16.03 |
| Fiscal year | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Operating cash flow | -$8.48M | -$11.2M | -$15.3M |
| Capital expenditures | $26.5K | $106K | $74.8K |
| Free cash flow | -$8.51M | -$11.3M | -$15.4M |
| Share buybacks | $11.3K | $3.69K | $2.00K |
| Fiscal year | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Cash & equivalents | $76.9K | $453K | $245K |
| Total assets | $26.3M | $28.0M | $109M |
| Total liabilities | $69.7M | $27.2M | $10.5M |
| Long-term debt | $14.3M | $13.2M | $2.57M |
| Shareholders' equity | -$43.4M | $792K | $98.2M |
| Retained earnings | -$74.8M | -$74.1M | -$212M |
| Shares (wtd avg diluted) | 382K | 354K | 8.62M |
Every figure is extracted from IP STRATEGY HOLDINGS, INC.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.